I completely agree that this is all very fishy and has taken way longer with unexpected with mysterious twist and turns, as has pretty much EVERYTHING with our investment here. What did happen to Lympro after all???

However, my guess as to the current delay - they are probably waiting to see if the testing ramp-up will create significant movement before doing what needs to be done to uplist (I won't say what, since last time I did, I was publicly flayed, even though it's been approved by the board). Would certainly make sense, if there is feeling that enough profit will be seen from Corona to lift the price.

This is one possibility.